FDA Adverse Event Other Summary report: N

SPONGE, BICOL, (COLLAGEN)

MDR report key: 2020267 · Received March 11, 2011

Report

Report Number
1226348-2011-00108
Event Type
Other
Date Received
March 11, 2011
Manufacturer
CODMAN & SHURTLEFF, INC.
Product Code
EFQ
PMA / PMN Number
PREAMEND
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

IT WAS COMMUNICATED THAT THE DEVICE AND/OR LOT NUMBER IS NOT AVAILABLE FOR INVESTIGATION. ADDITIONALLY, THERE WAS NO PRODUCT PROBLEM REPORTED. THE INSTRUCTIONS FOR USE CLEARLY INDICATE, UNDER WARNINGS AND PRECAUTIONS THAT THE DEVICE SHOULD NOT BE LEFT IN THE SITU. THE COMMENTS PROVIDED BY THE SURGEON WERE BASED ON USER PREFERENCE. THIS IS CONSIDERED TO BE AN ISOLATED EVENT. THIS IS THE FIRST COMPLAINT OF THIS KIND FOR THIS PRODUCT REPORTED. BASED ON THE RESULTS OF THIS INFO, NO FURTHER ACTION IS REQUIRED. TRENDS WILL BE MONITORED FOR THIS AND SIMILAR COMPLAINTS. AT THE PRESENT TIME, THIS COMPLAINT IS CLOSED.

Description of Event or Problem · 1

REP REPORTED THAT BICOL SPONGE WAS MISTAKEN FOR DURAGEN DURAL SUBSTITUTE AND ALMOST LEFT IN THE BRAIN. AS A RESULT, THE SURGERY WAS DELAYED AS THEY HAD TO REMOVE THE BONE FLAP TO REMOVE THE DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SPONGE, BICOL, (COLLAGEN) CODMAN BICOL SPONGE EFQ CODMAN & SHURTLEFF, INC. NA UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention